Enzymatica
1,74
SEK
+4,19 %
ENZY
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Vær den første som følger denne virksomhed
+4,19%
-8,42%
-26,27%
-37,28%
-52,3%
-52,78%
-79,29%
-58,17%
-69,54%
Enzymatica is a life science company that develops and sells medical devices for infection-related diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray which can prevent colds as well as shorten the illness period. The product has been launched on several markets and the strategy is to expand to more markets via partners. The company is headquartered in Lund.
Læs mereMarkedsværdi
422,36 mio. SEK
Aktieomsætning
188,51 t SEK
Omsætning
50,9 mio.
EBIT %
-94,42 %
P/E
-
Udbytteafkast, %
-
Finanskalender
18.2
2025
Årsrapport '24
29.4
2025
Delårsrapport Q1'25
17.7
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Enzymatica AB: Enzymatica announces outcome of new rights issue
Enzymatica AB: BioStock: Final study results - ColdZyme reduces illness duration and alleviates symptoms
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools